Compare Quest Diagnostics Inc (DGX) vs Fiverr International Ltd (FVRR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Fiverr International Ltd — how do they compare? Quest Diagnostics Inc trades at $229.97 (market cap $25.48B), while Fiverr International Ltd trades at $8.59 (market cap $310.61M). The key difference: Quest Diagnostics Inc is far larger — about 82× Fiverr International Ltd's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Fiverr International Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Fiverr International Ltd for 62 Days on average.
| DGX | FVRR | |
|---|---|---|
Market Cap | $25.48B | $310.61M |
Volume | 941,866 | 381,459 |
Sector | Health | Media |
52-Week High | $247.45 | $23.60 |
52-Week Low | $173.49 | $8.47 |
Typical Hold Time | 56 Days | 62 Days |
Enterprise Value | $31.23B | $63.00M |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.97, up 1.75% today, with a technical bias leaning bearish despite recent earnings beats. Revenue grew to $11.04B in 2025, with net income reaching $992M, though profit margins have moderated. Analyst consensus is a $250 price target with a mixed buy/hold sentiment. Recent news highlights growth in consumer testing and partnerships, alongside concerns over potential Medicare reimbursement cuts.
The outlook balances solid fundamentals and growth initiatives against regulatory risks. Upside potential exists from continued operational execution and new ventures like the Apple Health app integration, but investors face headwinds from reimbursement uncertainty and a high debt load. The stock's valuation appears reasonable relative to peers, supporting a cautious but opportunistic view.
Fiverr International (FVRR) trades at $8.72, up 2.59% today, but remains under pressure with bearish technical signals and recent earnings misses. The company reported Q2 2026 revenue of $97.8 million, down 10% year-over-year, as AI disruption impacts demand for lower-value freelance work. Despite attractive valuation metrics (P/E 10.67, P/S 0.76), the stock faces headwinds from declining revenue and negative cash flow trends.
The outlook remains challenging with AI compression affecting core business, though current valuations appear discounted. Investment opportunity exists if Fiverr successfully adapts to AI disruption, but risks include continued revenue decline and competitive threats. Analyst consensus is cautious with 76% hold ratings and $10.50 price target suggesting limited upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →
